Effects of CYP3A5 Polymorphisms on Efficacy and Safety of Tacrolimus Therapy in Patients with Idiopathic Membranous Nephropathy

• Egile Nagusiak: Zhang C (Egilea), Duan S (Egilea), Guo M (Egilea), Yuan Y (Egilea), Huang Z (Egilea), Zhu J (Egilea), Sun B (Egilea), Zhang B (Egilea), Xing C (Egilea)
• Formatua: Liburua
• Argitaratua: Dove Medical Press, 2020-04-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Chengning Zhang,1,* Suyan Duan,1,* Miao Guo,2 Yanggang Yuan,1 Zhimin Huang,1 Jingfeng Zhu,1 Bin Sun,1 Bo Zhang,1 Changying Xing1 1Departments of Nephrology; 2Department of Pharmacy, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, People’s Republic of C...